对于局部晚期胃癌的综合生存名录:基于大量人口的现实研究
Aizezi Maimaiti1,2, Yuan Zhou1,2, Dan Wang1,2
1Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Translational cancer research
|December 22, 2023
概括
这项研究开发了局部晚期胃癌 (LAGC) 总生存率 (OS) 和癌症特异性生存率 (CSS) 的预测性名录. 这些工具有助于临床医生为患有这种疾病的患者做出明智的决定.
科学领域:
- 在瘤学瘤学.
- 医学统计 医学统计
- 癌症研究 癌症研究
背景情况:
- 胃癌仍然是一个重大的全球健康挑战.
- 局部晚期胃癌 (LAGC) 具有复杂的治疗和预后考虑.
- 准确的生存预测对于有效的患者管理至关重要.
研究的目的:
- 在LAGC患者中构建和验证用于预测整体存活率 (OS) 和癌症特异性存活率 (CSS) 的nomograms.
- 确定影响生存结果的关键人口,病理和治疗因素.
- 为临床医生提供一个工具,以改善预后评估和治疗规划.
主要方法:
- 利用了来自监测,流行病学和最终结果 (SEER) 数据库的数据.
- 采用考克斯回归建模来识别生存的独立预测因素.
- 构建了包含13个显著变量,包括年龄,阶段和治疗方式的构建名录.
- 通过使用时间依赖的ROC曲线,DCA,C指数和校准曲线验证的nomogram性能.
主要成果:
- 开发并经过验证的nomograms准确地预测LAGC中的OS和CSS.
- 确定了OS和CSS的13个独立预测因素,包括人口,病理和治疗因素.
- 证明了构造的名ograms 的优越区分能力.
结论:
- 经过验证的诺姆图表作为可靠的工具来预测LAGC的生存率.
- 这些名图可以帮助临床医生做出更明智的治疗决策.
- 这项研究鼓励患者积极参与基于个性化预后的治疗.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
290
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.1K
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Kaplan-Meier Approach
149
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
149
